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INTRODUCTION
Liver resection is routinely used in the treatment 
of malignant and benign neoplasms [2, 13, 26]. The lat-
ter was achieved due to long-term efforts of scientists 
and clinicians in the field of oncology and hepatology 
for the last twenty years [16, 33]. Such types of opera-
tive interventions as extended liver resections, including 
those at patholo gical conditions of organ parenchyma 
or after chemothe rapy, and also repeated, simultane-
ous and staged resections were developed, and they are 
applied for the purpose of surgical treatment radicali-
ty and achievement of better long-term treatment out-
comes. Resulting from postsurgical reduction of func-
tioning parenchyma content in operated patients there 
is a growing threat of acute liver failure (ALF) develop-
ment in postoperative period. In spite of implementa-
tion in clinical practice of the results of studies of liver 
functional reserves with application of volumetry prin-
ciples and calculation of the volume of future residual 
liver stump (RLS), as well as application of portal vein 
(PV) embolization or associ ated liver partition and PV 
ligation, ALF remains the main cause of complications 
and patients’ mortality [1, 5].
Rate of ALF development is within 1.2–32.0%, and 
it depends on criteria of patient’s selection and operative 
intervention scope [21, 24]. In addition, the cause of the 
broad diapason of ALF diagnosing after liver resection 
may be the fact of absence of clear and generally recog-
nized criteria of this pathology determination. There-
fore the development of unified protocols with the aim 
of conduction of reliable comparison of different surgi-
cal centers results is extremely important. For applica-
tion of scientifically-based criteria of ALF development 
and its severity these protocols should be accessible and 
simple for use in wide spectrum of patients.
It is important to emphasize that metabolic and func-
tional alterations, including ALF after liver resection, are 
unique, and they often cause significant difficulties during 
patient’s condition correction. Deep understanding of  liver 
physiology and its alterations should allow surgeons and 
anes thesiologists to resolve postoperative issues properly. 
Strategies that are needed for realization in postoperative pe-
riod to improve treatment outcomes include adequate nu-
tritive support, appropriate glycemic control and measures 
for reduction of postoperative infectious complications.
Consensus in ALF grade diagnostics in postoperative 
period at liver resection. Meta-analysis of literature data 
revealed 1928 scientific papers dedicated to examination 
of ALF problem [25]. In their publication the authors used 
different interpretations of ALF term determination. This 
confirms the fact that there is no generally accepted sci-
entifically-based determination of ALF term. Qualita-
tive variants of ALF determination included one or sev-
eral symptoms of liver function disorder in postoperative 
period, namely: coagulopathy, hyperbilirubinemia, ascite 
and encephalopathy, etc. [29, 30]. Most commonly the au-
thors provided ALF assessment basing on laboratory tests, 
using serum bilirubin levels and international normalized 
ratio (INR) or prothrombin index as diagnostic criteria. 
Some authors for ALF detection assessed clinical symp-
toms/syndromes in combination with the results of liver 
functi onal state [7, 26]. In a number of scienti fic papers the 
principles of ALF severity assessment were developed [8, 
10], and some authors dedicated their work to examina-
tion of markers and factors for prognostication of ALF ef-
fect on postoperative patient’s mortality. In that way Bal-
zan and others in 2005 within the framework of their in-
vestigation analyzed treatment outcomes of 704 patients 
that underwent liver resection and had ALF signs in post-
operative period. The latter was diagnosed by INR level 
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< 50% and serum bilirubin > 50 mM/L on the day 5 of 
postoperative period that became stable correlation mark-
er of mortality development in postoperative period [34]. 
In the other study Mullen et al. (1059 patients without cir-
rhosis and liver insufficiency in preoperative period) dis-
covered that peak bilirubin concentrations in blood serum 
(> 7 mg/mL) are potent predictors of ALF terminal stages 
development and postoperative mortality, and high levels 
of postoperative complications in patients that underwent 
“major” liver resections (≥ 3 segments) [20]. In contrast 
to the above-mentioned results Schindl and co-authors 
proposed classification of ALF severity grades. Differen-
tial diagnosis criteria comprised 4 parameters (level of to-
tal bilirubin in blood serum, INR, lactate serum concen-
tration and degree of encephalopathy), according to these 
levels the authors proposed to determine 4 grades of ALF.
Standard biochemical analysis of liver values and 
coagulograms in postoperative period in patients that 
were subjected to operative liver interventions demon-
strates that in majority of such patients the overall le-
vel of serum bilirubin fractions and INR are normalized 
on the day 5 of postoperative period, including the pa-
tients that underwent extended “major” resections [17].
Considering these data and their own experience au-
thors of consensus 2015 [21] claim that ALF after liver 
resection is a loss of liver ability to perform synthetic, ex-
cretory and detoxication functions that is accompanied 
with increased INR levels and simultaneous growth in to-
tal bilirubin concentration in blood serum on the day ≥ 5 
of postoperative period.
It is recommended to determine pathological va lues 
of coagulogram and blood serum bilirubin  according to 
laboratory standards. Such criteria should be applied 
to patients both with physiological liver parenchyma con-
dition and with pathologically altered liver condition. 
It is important to emphasize that in case of presence of 
patho logical INR or bilirubin values in individual pa-
tient at preoperative stage ALF diagnosis on the day 
≥ 5 of postoperative period is made comparing levels of 
serum bili rubin and INR with the same indices on the 
day 4. The necessity of administration of blood coagula-
tion factors to patients, for example, fresh frozen plasma 
(FFP), to achieve INR normalization on the day ≥ 5 of 
postoperative period in combination with hyperbilirubi-
nemia should be also considered as ALF.
Grades of ALF severity in postoperative period in pa-
tients that underwent liver resection. ALF may have tran-
sient nature because after liver resection its function may 
recover resulting from organ’s ability for regeneration, 
and thus to restore its function. In other cases the loss 
of liver function may become potential life threat for ope-
rated patient. In addition to previous recommendations 
on ALF diagnosing in postoperative period, it is recom-
mended to assess severity grade of this pathology (Table).
Grade of ALF severity in operated patients should be 
determined by most pronounced criteria (it is reasonable 
to consider 1 criterion of invasive or non-invasive treat-
ment methods when differential diagnosis is discerned 
between grades C and B).
Table
ALF severity grades in postoperative period in patients that were 
subjected to liver resection  
(International Study Group of Liver Surgery — ISGLS)
Determination ALF — is a loss of liver ability (in patients both with nor­
mal and pathologically altered liver function before ope­
ration) to perform synthetic, excretory and detoxification 
functions that is accompanied by increase of INR levels 
(or require administration of blood coagulation factors 
for INR normalization) and hyperbilirubinemia (accord­
ing to local laboratory data) on the day 5 of postopera­
tive period and later. In case of detection of increased 
 levels of INR and blood serum bilirubin ALF is determi­
ned by increase of INR level (decrease of prothrombin 
index) and hyperbilirubinemia on the day ≥ 5 after  liver 
resection, comparing with previous day. Other causes 
of hyperbilirubinemia should be excluded, in particular, 
mechanical obstruction
Grades
А ALF leading to abnormality of normal laboratory values 
although without need of additional correction of pa­
tient’s therapy
В ALF leading to abnormality of normal laboratory va lu­
es, and non­invasive correction of patient’s condition 
is possible
С ALF leading to abnormality of normal laboratory values 
and requires invasive tactics in patient’s treatment
ALF of Grade А in postoperative period suggests li ver 
function impairment, although it does not have impact 
on changes in patient’s therapy tactics. This ALF grade can 
be determined basing on detected deterioration of initial le-
vel of routine laboratory tests. Such patients do not have new 
symptoms comparing with standard disease course and can 
be treated in usual in-patient regimen.
ALF of Grade В in postoperative period suggests the need 
for adjustment of conservative treatment tactics, although pa-
tient’s condition can be stabilized without application of in-
vasive methods. Non-invasive treatment can comprise indi-
cation of FFP, albumin, diuretics and non-invasive  methods 
of lungs ventilation. In addition, alteration in treatment tac-
tics and application of intensive therapy are possible only in 
case of determination of parenchyma dysfunction of RLS 
that is classified as Grade B of ALF. These patients require 
additional diagnostic measures, in particular, ultrasound and 
spiral CT, to exclude mechanical obstruction of bile ducts 
and presence of abscesses and circumscribed fluid collec-
tions. It the signs of infectious complications are present (leu-
cocytosis, etc.) it is necessary to perform plain radiography 
of thoracic organs and bacterial inoculation of dischar ges, 
blood and urine. Brain CT should be performed to exclude 
other cases of patient’s condition deterioration. Patients with 
ALF Grade B may have clinically significant ascites, in ad-
dition the increase of body weight and moderate respiratory 
insufficiency can be registered. Such patients usually require 
moderate/intensive therapy, although experienced nurses 
can provide appropriate care to such patients also in inpa-
tient conditions without resuscitation use.
Grade C of ALF. Such patients require invasive methods 
of postoperative condition correction. Invasive procedures 
include hemodialysis, tracheal intubation and mechanical 
ventilation, extracorporal liver support, “rescue” hepatec-
tomy and transplantation. Even more, for patients, receiving 
cardiologic support (including vasoactive preparations) due 
to ALF, the latter should be classified with Grade C as well 
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as in patients, receiving glucose solution infusion for persis-
tent hypoglycemia. Patients with ALF Grade C are in severe 
condition therefore the provision of medical aid to such pa-
tients should be performed in resuscitation conditions. Clini-
cal picture of such patients is characterized with abundant 
ascites, generalized edemas, hemodynamics instability, pro-
nounced respiratory disorders and encephalopathy. In addi-
tion, ALF Grade C is a risk factor for generalized infections 
deve lopment, therefore antibiotic therapy should be applied 
for prophylactic purposes, although such a tactics should be 
confirmed with subsequent clinical studies.
Control of fluids and electrolytes. Early postoperative 
period after liver resection is characterized by imbalance 
of fluid and electrolytes that is caused by functional dis-
order of RLS. Maintenance of adequate balance of fluids 
and normal kidneys function is crucial considering vaso-
dilation-induced hypotension. In such conditions colloid 
solutions lead to restoration of intravascular volume. Limi-
ted indication of infusion solutions with high sodium con-
tent and rational use of diuretics is also recommended [19].
It is believed that hyperlactatemia and hypophospha-
temia are the most frequent disorders in patients that un-
derwent liver resection. Because of ALF conditions the li-
ver produces lactate, but it does not metabolize it. In these 
conditions lactate and bilirubin levels in blood serum can 
be the criteria of assessment of cellular hypoxia level and 
predictors of mortality and treatment quality. Therefore it 
is not recommended to prescribe lactate-containing solu-
tions in postoperative period to such patients.
Hypophosphatemia is found in almost all the patients 
after major liver resections. Pathogenesis of hypophospha-
temia after liver resection is poorly examined. Cellular hy-
poxia caused by glycolysis both of tumor genesis and li-
ver trauma determines accumulation of organic phosphate 
compounds at simultaneous reduction of intracellular or-
ganic phosphate. With phosphate diffusion in cells decrease 
of its level in blood occurs that leads to hypophosphatemia. 
Decrease of intracellular inorganic phosphate due to this 
mechanism is a critical element and it can lead to ATP de-
pletion and initiate generation of superoxide radicals by in-
tracellular and extracellular sources. It is known that in un-
complicated cases phosphorylated compounds are meta-
bolized in tricarboxylic acid cycle, providing restoration of 
ATP levels. At more severe phosphates depletion ATP de-
ficit may become a cause of cellular dysfunction develop-
ment in different organs and systems. Hypophosphatemia 
and energy exchange deteriorations, induced by it, lead to 
pathological alterations, causing, in particular, cardiac ar-
rhythmias, alterations in hematopoietic system, insulin-re-
sistance and neuromuscular dysfunctions [18].
Standard treatment at liver resections should include 
adequate phosphate restoration by infusion of solutions, 
containing potassium phosphate and also, in case when 
the patent can take meals — his/her ration should be cor-
rected. Assessment of above described changes is possi-
ble by measuring phosphates levels in serum, in particu-
lar, serum 2,3-diphosphoglycerol levels, and also nucleo-
tide products in urine that are more sensitive physiological 
markers. Low levels of 2.3 diphosphoglycerol in serum and 
high levels of nucleotides and theirs degradation products 
in urine indicate insufficient intracellular phosphate le vel. 
In general, hypophosphatemia after liver resection may 
lead to perilous consequences and therefore it should be 
properly corrected. Further studies that in prospect will 
help to discover pathophysiology of hypophosphatemia 
after liver resection may promote treatment improvement.
Diet. In post-resection period liver parenchyma is cha-
racterized by catabolic condition, and frequently — with 
disproportion of glucose and electrolytes levels that does 
not promote prompt liver regeneration. Nutritional sup-
port in this critical period is paramount for provision of ade-
quate regeneration and postoperative rehabilitation. Indi-
vidual diet plans should be developed for patients conside-
ring liver function since these patients demonstrate changes 
in amino acids metabolism. In such patients’ blood low le-
vel of circulating amino acids with branched chain (leu-
cine, isoleucine, valine), methionine and aromatic amino 
acids is registered. Therefore introduction of amino acids 
with branched chain into the diet may facilitate accelera-
tion of patients’ rehabilitation after liver resection [3]. En-
teral nutrition does not influence patients’ mortality, but it 
improves immune indices and reduces postoperative infec-
tious complications. We support enteral nutrition applica-
tion in case when contraindications are absent.
Glycemic control. It is known that non-alcoholic fat-
ty liver disease (NFLD) in one of the leading causes of 
transaminases level rise in blood serum in case of liver 
cirrhosis exclusion [9]. NFLD is accompanied with ste-
atosis (excessive triglycerides accumulation), steatohepa-
titis (impairment of hepatocytes, infiltration with anti-in-
flammatory cells and fibrosis) and cirrhosis [31], the latter 
changes may be histologically confirmed. NFLD is often 
associated with diabetes mellitus and obesity, which in-
cidence rate requires to consider situation in the world as 
epide mic [4]. It is noteworthy to mention that not all the 
patients with diabetes mellitus and obesity have NFLD.
It is known that a number of chemotherapeutic prepa-
rations have hepatotoxic effects. In particular, irinotecan- and 
5-fluorine uracil-based chemotherapy results in steatohepa-
titis development in 20 and 5% of cases, respectively [20, 27]. 
Whereas oxaliplatin prescription is associated with develop-
ment of sinusoidal obstruction syndrome [24, 27, 32]. Alcohol 
intake also is a common cause of liver steatosis development. 
Liver steatosis is associated with increased risks of complica-
tions in postoperative period, and moderate or pronounced 
steatosis correlates with high mortality rates and ALF after 
surgical treatment [6]. Diabetes mellitus and obesity are in-
dependent risk factors of postoperative complications (infec-
tious, cardiovascular, renal) at major liver resections.
Hyperglycemia, induced by surgical stress, causes dis-
orders of liver metabolism regulation and immune func-
tion that may become an adverse factor for postopera-
tive outcomes. Control of blood glucose level and inten-
sive insulin therapy of patients reduce complications and 
mortality. Insulin resistance after liver resection can make 
the control of adequate blood glucose level challenging.
Coagulation system control. Control of such blood coagu-
lation indices as INR/PTI, especially on the day 2–5 of post-
ОНКОЛОГИЯ •  Т.  18 •  № 1 •  2016
Обз Ор
18
operative period is a critically important procedure. Patho-
logical changes of these indices correlate with liver resection 
volume and develop due to reduction of organ stump syn-
thetic function, and also in cases of peri- and postoperative 
hemotransfusion and application of blood coagulation fac-
tors. Prophylactic administration of FFP is recommended 
at INT ≥ 2.0 to prevent bleeding. There is evidence that pro-
phylactic FFP transfusions at PTI > 16 sec in patients that 
underwent liver resection are important for prevention of re-
peated liver metastatic spread at colorectal cancer. And com-
bination of administration of FFP, vitamin K preparations, 
octreotide and VIIa coagulation factor can be used for co-
agulopathy correction and bleeding prevention at ALF signs.
Postoperative infections prevention. Infections after liver 
resections are one of the main reasons of postoperative mor-
bidity and mortality that also influence the results of long-
term prognosis. Risk factors of postoperative infectious com-
plications are obesity, presence of preoperative bile drainage, 
operative blood loss, concomitant diseases and bilomas in 
postoperative period. Early postoperative infections detec-
tion, application of broad-spectrum antibiotics and infec-
tion control are paramount. In patients that underwent li-
ver resection functional impairment of intestinal barrier and 
intestinal-microbial balance was found, leading to systemic 
inflammations and infectious complications. Therefore ear-
ly enteral feeding is aimed at intestinal barrier function pro-
tecting and infectious complications reduction.
It is believed that for prevention of postoperative com-
plications it is necessary to apply synbiotic treatment. It is 
known that probiotics are the bacteria that in symbiosis with 
host provide host with benefit improving intestinal microbi-
al balance. Whereas probiotics is a group of microorganisms, 
not affecting the digestion of food components, but selective-
ly altering the growth and activity of large bowel microflora. 
And combination of pro- and prebiotics is a synbiotic therapy.
Sinusoidal obstruction syndrome and its effect on liver 
function. In 1920 the disease, leading to occlusion of liver pa-
renchyma veins as a result of pyrrolysine alkaloids poisoning 
was described, at that moment morphologists determined 
central veins affection, and also liver sinusoid veins [14]. In 
1999 DeLeve et al. presented the model of the disease with 
liver veins occlusion in rat model, this pathology was induced 
by monocrotaline [11]. Pathomorphological alterations that 
are macroscopically described as “blue liver” are well known 
under the term “sinusoidal obstruction syndrome” (SOS). 
According to resent years publications SOS is often deter-
mined in patients with colorectal cancer with liver metastatic 
affection which were prescribed with chemotherapy. Under 
the term SOS sinusoidal membrane impairment, collagen 
deposition in perisinusoidal space and sinusoidal di latation 
is implied. SOS pathophysiology comprises the process of 
increase of superoxide radicals levels and nitrogen oxide 
radi cals, F-actin depolymerization in vascular endothelial 
cells, and increased activity of matrix metalloprote inases 
( MMP-9 and -2) in vascular endothelial cells [12, 23]. Ac-
cordingly, SOS is associated with fibrosis development, and 
further — with portal hypertension, liver insufficiency.
In 2004 Rubbia-Brandt et al. were the first who pub-
lished clinical data on SOS that had developed after neo-
adjuvant polychemotherapy in patients with metastatic 
colorectal cancer [24]. The authors proposed classification 
of SOS (0 — changes are absent, 1 — mild degree, central 
lobule affected up to ⅓ of the surface; 2 — moderate de-
gree, central lobule affected up to ⅔ of its surface; 3 — pro-
nounced changes, complete lobule affection). According to 
this study data SOS was diagnosed in 34 (79.1%) of 43 pa-
tients that were prescribed with oxaliplatin. In the studi-
es [15, 22, 28] correlation between SOS and prescription 
of chemotherapy schemes based on oxaliplatin and 5-flu-
orine uracil was demonstrated: in 8.3 — 51.6% cases che-
motherapy-associated SOS of 2–3 degree developed. Se-
verity of ALF in postoperative period correlates with num-
ber of courses of neoadjuvant chemotherapy provided [15], 
and postopera tive complications, associated with liver dys-
function, are more specific for patients with already exis-
ting liver diseases [13]. Short course of polychemotherapy 
on the base of oxaliplatin is not associated with early post-
operative complications rise. At SOS that resulted from to-
xic chemotherapy effect increase of resistance to blood flow 
between PV system and hepatic veins occurs. Therefore 
arising portal hypertension leads to splenomegaly, refrac-
tory thrombocytopenia, bleeding from esophageal varices, 
hemorrhoidal veins. Thus, SOS development is accompa-
nied with decrease of efficacy of oxaliplatin-based neoad-
juvant polychemotherapy which in turn worsens long-term 
outcomes of surgical treatment. And cellular hypoxia is the 
most important factor, influencing disease course.
CONCLUSION
Thereby, we consider that proposed ALF determi-
nation [21] and scale will be applied in future research, 
 aiming to standardize surgical complications in postope-
rative period and to be able to provide stratified compa-
rison of immediate results of studies with liver resections 
conducting. And investigation of physiological alterations 
in the tissues of operated liver of oncologic patients will 
allow in the future to improve algorithms of ALF diag-
nostics and management.
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ПРИНЦИПИ ВИЯВЛЕННЯ ГОСТРОЇ 
ПЕЧІНКОВОЇ НЕДОСТАТНОСТІ 
ТА ЇЇ КОНТРОЛЮ В РАННІЙ 
ПІСЛЯОПЕРАЦІЙНИЙ ПЕРІОД
А.А. Бурлака, О.О. Колеснік
Резюме. Незважаючи на впровадження в клініч­
ну практику результатів вивчення функціональ­
них резервів печінки із застосуванням принципів 
волюметрії та розрахунку об’єму майбутньої за­
лишкової культі цього органа, так само як і засто­
сування емболізації ворітної вени чи асоційовано­
го розділення печінки та лікування ворітної вени, 
гостра печінкова недостатність (ГПН) залиша­
ється основною причиною ускладнень і смертності 
хворих в післяопераційний період. Метою огляду був 
аналіз нових підходів до профілактики ГПН та її 
контролю. Запропоноване визначення ГПН і шкала 
ISGLS (Rahbari N.N. et al., 2015) будуть викорис­
тані у майбутніх дослідженнях з метою стандар­
тизації хірургічних ускладнень у після операційний 
період та можливого стратифікованого порів­
няння безпосередніх результатів досліджень із ви­
конанням резекції печінки. Вивчення фізіологічних 
змін у тканинах оперованої печінки хворих онколо­
гічного профілю дозволить покращити алгоритми 
діагностики та управління ГПН.
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